Clinical Trials in San Francisco

Showing 721-740 of 12,991 trials

A Study of ZL-1310 in Participants With Selected Solid Tumors

NCT06885281

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Zai Lab (Shanghai) Co., Ltd.112 participantsStarted May 2025

San Francisco, California, United States • Detroit, Michigan, United States • New York, New York, United States +17 more locations

RECRUITINGPhase 3< 1 mile

Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

NCT06605118

This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin prophylaxis or to placebo. Both groups also will receive standard of care preoperative antibiotics (excluding azithromycin). The primary endpoint is a maternal infection composite defined as any one of the following up to 6 weeks postpartum: endometritis, wound infection, abscess, septic thrombosis, sepsis, pneumonia, pyelonephritis and breast infection.

Obstetrical ComplicationsLabor and Delivery ComplicationCesarean Delivery

The George Washington University Biostatistics Center8,000 participantsStarted Nov 2024

Birmingham, Alabama, United States • San Francisco, California, United States • Chicago, Illinois, United States +11 more locations

A Study of ZL-1310 in Participants With Selected Solid Tumors

Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

Find Trials by Condition in San Francisco

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Pilot Study of Patient Navigation for Kidney Stone Patients After ED Visits

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11)

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout

A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders

Anesthesia-Masked Psilocybin Therapy for Major Depression

Hyperangulated Versus Standard Geometry Laryngoscope Blade Trial

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC

Cephea Early Feasibility Study

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

Education & Mentorship of Advanced Practice Providers to Increase Community-based Research Within the NCORP Network, COACH-APP Trial